- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02266654
Early Goal Directed Therapy in Sepsis by Emergency Medical Services
Early Goal Directed Therapy in Sepsis by EMS
The goal is to evaluate the best way for paramedics and hospitals to work together to treat septic patients as quickly as possible.
The investigators think that the best thing to do for septic patients is to identify and treat them as early as possible. This research will test this. The investigators think that if paramedics identify septic patients and begin treatment with fluids in the ambulance, then the patient will do better in the long run. The paramedic will also tell the hospital that a septic patient will be there soon. The caregivers can prepare and be ready to provide care as soon as the patient arrives. With this research, the investigators would like to see if these steps help patient outcomes.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Cambridge, Massachusetts, United States, 02138
- Mount Auburn Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Older than 17 years of age
- Suspected to having an infection
- Meets 2 of 3 systemic inflammatory response criteria: heart rate > 90 beats per minute, respiratory rate >20 breaths per minute, temperature >38°C or <36°C
Exclusion Criteria:
- Transfer from another hospital
- Patients, coming from a rehabilitation/nursing facility where antibiotics were given prior to transfer
- Pregnant patients
- Prisoners.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Prehospital-directed therapy arm
Patients who are hypotensive or whose lactate is ≥ 2.5, prehospital providers will provide a notification to the receiving hospital (Hospital Notification), establish an IV, and provide 1 liter normal saline (NS) bolus of IV fluids.
An additional 1 liter normal saline bolus will be given for systolic blood pressure less than 100.
Patients who have a history of end-stage renal disease or congestive heart failure would receive only 20 milliliters/kilogram of fluid.
If the patient remains hypotensive, Emergency Medical Services will continue providing fluids as is standard of care.
|
Normal Saline 0.9%
Prehospital providers will notify the receiving hospital over the radio or telephone that they are transporting a patient who meets Sepsis Criteria
|
Experimental: Control Arm
Prehospital providers will obtain a point of care lactate, establish an IV, and provide IV fluids as judged necessary.
|
Normal Saline 0.9%
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Time to antibiotics
Time Frame: During the Emergency Department stay (expected to be 5 hours)
|
During the Emergency Department stay (expected to be 5 hours)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Mortality
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 1 week
|
Participants will be followed for the duration of hospital stay, an expected average of 1 week
|
Need for pressors in the Emergency Department
Time Frame: During the Emergency Department stay (expected to be 5 hours)
|
During the Emergency Department stay (expected to be 5 hours)
|
Admitted to the Intensive Care Unit from the Emergency Department
Time Frame: During the Emergency Department stay (expected to be 5 hours)
|
During the Emergency Department stay (expected to be 5 hours)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michael Filbin, MD, Massachusetts General Hospital
- Principal Investigator: William Porcaro, MD, MPH, Mount Auburn Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 019-2014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sepsis
-
University of Kansas Medical CenterUniversity of KansasRecruitingSepsis | Septic Shock | Sepsis Syndrome | Sepsis, Severe | Sepsis Bacterial | Sepsis BacteremiaUnited States
-
Jip GroenInBiomeRecruitingMicrobial Colonization | Neonatal Infection | Neonatal Sepsis, Early-Onset | Microbial Disease | Clinical Sepsis | Culture Negative Neonatal Sepsis | Neonatal Sepsis, Late-Onset | Culture Positive Neonatal SepsisNetherlands
-
Karolinska InstitutetÖrebro University, SwedenCompletedSepsis | Sepsis Syndrome | Sepsis, SevereSweden
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknown
-
Ohio State UniversityCompletedSepsis, Severe Sepsis and Septic ShockUnited States
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityRecruitingSevere Sepsis | Severe Sepsis Without Septic ShockUnited States
-
University of LeicesterUniversity Hospitals, Leicester; The Royal College of AnaesthetistsCompletedSepsis | Septic Shock | Severe Sepsis | Sepsis SyndromeUnited Kingdom
-
Zagazig UniversityRecruitingSepsis-associated EncephalopathyEgypt
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI); New York Presbyterian Hospital and other collaboratorsCompletedSepsis | Septic Shock | Severe Sepsis | Infection | Sepsis SyndromeUnited States
Clinical Trials on IV fluids
-
University of CalgaryMcGill University; University of Ottawa; Queen's University; Halton Health (Oakville) and other collaboratorsRecruiting
-
Stanford UniversityCompleted
-
Bnai Zion Medical CenterCompletedViral BronchiolitisIsrael
-
Samsung Medical CenterCompleted
-
Austin HealthCompletedCardiac SurgeryAustralia
-
The Hospital for Sick ChildrenCompleted
-
Federal University of Minas GeraisCompletedThirst | Postoperative Nausea | Postoperative Vomiting | Hunger | Fluid Electrolyte Disorders | Renal Function Abnormal
-
University of CalgaryMedical University of South Carolina; University of Colorado, Denver; The Hospital... and other collaboratorsRecruitingHemolytic-Uremic Syndrome | Shiga Toxin-Producing Escherichia Coli (E. Coli) InfectionUnited States, Canada
-
Mt. Sinai Medical Center, MiamiFlorida Heart Research InstituteCompleted
-
University of AarhusAarhus University HospitalCompletedCoronary Artery Disease | Fluid Overload | HypovolemiaDenmark